6601 - 6650 of 8825 Results
Title
Year
- A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease2023RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
-
RESTRICTEDTitle: Chronotype, sleep, and sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105189End Page: 105189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.011Citation Count: 11
- History of high household pesticide use and Parkinson's disease in Brazil2023RESTRICTEDTitle: History of high household pesticide use and Parkinson's disease in BrazilJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 113Issue #:Start Page: 105493End Page: 105493Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105493Citation Count: 11
-
OPENTitle: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagyJournal Name: SLAS DiscoveryPublisher: Elsevier BVVol: 28Issue #: 3Start Page: 73End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004Best OA location URL: http://slas-discovery.org/article/S2472555222137160/pdfCitation Count: 16
-
OPENTitle: Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 107Issue #:Start Page: 105251End Page: 105251Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.105251Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10028594/pdf/nihms-1882881.pdfCitation Count: 5
-
OPENTitle: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103085End Page: 103085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2023.103085Best OA location URL: https://doi.org/10.1016/j.scr.2023.103085Citation Count: 3
- Valbenazine as treatment for Huntington's disease chorea2023RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 5
-
OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 4
-
OPENTitle: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceJournal Name: Value in HealthPublisher: Elsevier BVVol: 26Issue #: 4Start Page: 449End Page: 460Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006Best OA location URL: http://www.valueinhealthjournal.com/article/S1098301522047805/pdfCitation Count: 33
-
OPENTitle: Adult-specific Reelin expression alters striatal neuronal organization: implications for neuropsychiatric disordersJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page: 1143319End Page: 1143319Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2023.1143319Best OA location URL: https://doi.org/10.3389/fncel.2023.1143319Citation Count: 11
-
OPENTitle: The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1138546End Page: 1138546Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1138546Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1138546/pdfCitation Count: 1
-
OPENTitle: Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1069411End Page: 1069411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1069411Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1069411/pdfCitation Count: 65
-
OPENTitle: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 933End Page: 942Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13747Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10272891/pdf/MDC3-10-933.pdfCitation Count: 6
-
OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: Springer Science and Business Media LLCVol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8804990Citation Count: 15
-
OPENTitle: Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in OsteosarcomaJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 21Issue #: 6Start Page: 903End Page: 913Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1158/1535-7163.mct-21-0836Best OA location URL: https://aacrjournals.org/mct/article-pdf/21/6/903/3191485/903.pdfCitation Count: 31
-
OPENTitle: Toward preventing Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 818End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add7162Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/113804Citation Count: 15
-
OPENTitle: Unveiling the B cell receptor structureJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 819End Page: 820Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add8065Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11044948Citation Count: 12
-
OPENTitle: A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversityJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 17Start Page: eabn0044End Page: eabn0044Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abn0044Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abn0044?download=trueCitation Count: 42
-
OPENTitle: Membrane curvature sensing and stabilization by the autophagic LC3 lipidation machineryJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 50Start Page: eadd1436End Page: eadd1436Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.add1436Best OA location URL: https://escholarship.org/uc/item/39r5f1mnCitation Count: 43
- Mapping microstructural gradients of the human striatum in normal aging and Parkinson’s disease2022OPENTitle: Mapping microstructural gradients of the human striatum in normal aging and Parkinson’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 28Start Page: eabm1971End Page: eabm1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abm1971Best OA location URL: https://doi.org/10.1126/sciadv.abm1971Citation Count: 50
-
OPENTitle: Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencingJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 9Start Page: eabm5386End Page: eabm5386Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abm5386Best OA location URL: https://doi.org/10.1126/sciadv.abm5386Citation Count: 180
- Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease2022RESTRICTEDTitle: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page: eabj2658End Page: eabj2658Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abj2658Citation Count: 241
- Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response2022OPENTitle: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication responseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 663Start Page: eadc9669End Page: eadc9669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669Citation Count: 102
-
OPENTitle: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein VariantsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1790End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00190Citation Count: 6
- Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation2022OPENTitle: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and DifferentiationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 23Start Page: 3281End Page: 3290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12316044Citation Count: 20
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022OPENTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 22
-
OPENTitle: Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 InhibitorsJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 7Issue #: 16Start Page: 14252End Page: 14263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acsomega.2c00889Best OA location URL: https://doi.org/10.1021/acsomega.2c00889Citation Count: 7
-
OPENTitle: Untwisted α-Synuclein Filaments Formed in the Presence of Lipid VesiclesJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 61Issue #: 17Start Page: 1766End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.2c00283Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10289115/pdf/nihms-1906828.pdfCitation Count: 16
-
OPENTitle: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort StudyJournal Name: Diabetes CarePublisher: American Diabetes AssociationVol: 46Issue #: 2Start Page: 297End Page: 304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2337/dc22-1705Best OA location URL: https://diabetesjournals.org/care/article-pdf/46/2/297/696578/dc221705.pdfCitation Count: 129
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 6
- Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—Reply2022RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—ReplyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21011Citation Count: 4
- Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease2022RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21008Citation Count: 5
-
OPENTitle: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood FactorsJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 10Start Page: e2235068End Page: e2235068Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797044/hajjar_2022_oi_220997_1664303851.08078.pdfCitation Count: 98
-
OPENTitle: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 7Start Page: e2223821End Page: e2223821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdfCitation Count: 13
-
OPENTitle: Association of Essential Tremor With Novel Risk LociJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 185End Page: 185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4781Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2787239/jamaneurology_liao_2022_oi_210083_1644604359.06757.pdfCitation Count: 37
-
OPENTitle: Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 6Start Page: 592End Page: 592Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0676Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9016616Citation Count: 75
-
OPENTitle: Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 4Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0003Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2789505/jamaneurology_simonet_2022_oi_220001_1649435706.38428.pdfCitation Count: 83
-
OPENTitle: Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 1Start Page: 32End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4222Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2786605/jamaneurology_gonzalez_2021_oi_210074_1643670411.5671.pdfCitation Count: 98
-
OPENTitle: Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 652End Page: 652Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1166Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2793004/jamaneurology_le_guen_2022_oi_220025_1656444964.82183.pdfCitation Count: 87
- Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits2022RESTRICTEDTitle: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock BenefitsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 12Start Page: 1219End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649Citation Count: 6
- Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply2022RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
OPENTitle: Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma BiomarkersJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 11Start Page: 1155End Page: 1155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.3265Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9552044Citation Count: 45
- Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?2021RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 5
- Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease2022RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
-
OPENTitle: Six Action Steps to Address Global Disparities in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 9Start Page: 929End Page: 929Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2793874/jamaneurology_schiess_2022_sc_220001_1662471546.98796.pdfCitation Count: 134
- Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities2022RESTRICTEDTitle: Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental DisabilitiesJournal Name: Psychiatric ServicesPublisher: American Psychiatric Association PublishingVol: 73Issue #: 12Start Page: 1389End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ps.202100524Citation Count: 16
-
RESTRICTEDTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Best OA location URL: https://psyarxiv.com/zvqge/downloadCitation Count: 5
-
OPENTitle: Sex and Gender Influence Urinary Symptoms and Management in Multiple System AtrophyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 16Issue #: 2Start Page: 196End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.23016Best OA location URL: https://www.e-jmd.org/upload/jmd-23016.pdfCitation Count: 6
-
OPENTitle: Local genetic correlations exist among neurodegenerative and neuropsychiatric diseasesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 70End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00504-1Best OA location URL: https://www.nature.com/articles/s41531-023-00504-1.pdfCitation Count: 20
-
OPENTitle: Single‐cell sequencing of entorhinal cortex reveals widespread disruption of neuropeptide networks in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 8Start Page: 3575End Page: 3592Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12979Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12979Citation Count: 9